Skip to main content
. Author manuscript; available in PMC: 2018 Apr 23.
Published in final edited form as: Per Med. 2017 Jun 23;14(4):339–354. doi: 10.2217/pme-2016-0104

Figure 3. Effectiveness and feasibility scores for solutions to proprietary databases.

Figure 3

(B1) Make data sharing and the possibility of independent verification a condition of approval/clearance, certification, or accreditation (specifically, a requirement set forth by FDA, CMS/Clinical Laboratory Improvement Amendments, and/or College of American Pathologists). (B2) Make data sharing and sufficient transparency for independent verification a condition of funding (specifically, a requirement for NIH funding. (B3) Use positive-economic incentives so that payers reimburse more for tests from laboratories that share data. (B4) Use negative-economic incentives. For example, payers refuse to pay, or healthcare providers refuse to order tests, if there is no data sharing. (B5) Public shaming of companies that do not share. (B6) Do nothing. You cannot or should not compel data disclosure in this space.

CMS: Centers for Medicare and Medicaid Services.